-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Jefferies Adjusts Fate Therapeutics Price Target to $15 From $30, Maintains Buy Rating

Jefferies Adjusts Fate Therapeutics Price Target to $15 From $30, Maintains Buy Rating

MT Newswires · 01/06/2023 03:30